HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that it has closed on the Company’s previously announced strategic partnership agreement with Oramed Pharmaceuticals Inc. (Nasdaq: ORMP). The transaction has positioned Lifeward as a diversified biomedical innovation company with an ...

Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval; Lifeward gains new oral protein delivery technology platform Lifeward already executing new strategy through acquisition of powered upper-body exoskeleton technology Lower operating expenses and cash usage reflect improved operational efficiency HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 18, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. ...

HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 11, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced it has received a notification letter from The Nasdaq Stock Market LLC ("Nasdaq") confirming that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) ("Rule"). To regain complia ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its fourth quarter and full year 2025 financial results before the markets open on Wednesday, March 18, 2026. Mark Grant, President and Chief Executive Officer, and Almog Adar, Chief Financial Officer ...

IP and technology acquisition is expected to be highly accretive and to advance Lifeward’s position as a diversified biomedical innovation companyWill Expand Lifeward’s portfolio beyond lower-limb solutions, creating a differentiated, whole-body neuro-rehabilitation portfolio Will Strengthen long-term strategic networks with neuro-rehabilitation prescribers, rehabilitation networks, and payers HUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” ...

Reverse split initiated as Lifeward enters strategic partnership agreement and repositions as MedTech innovation companyHUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical limitations or disabilities, today announced that effective with the open of the market on February 24, 2026, the Company will complete a 1-for-12 rever ...

Core Insights - Lifeward Ltd. has appointed Bob Marshall as the new Chairman of the Board, effective January 1, 2026, succeeding Joseph Turk who is transitioning to a new role at Fresenius Medical Care [1][2] Company Overview - Lifeward is a global leader in innovative medical technology aimed at transforming the lives of individuals with physical limitations or disabilities [3] - The company designs, develops, and commercializes solutions for physical rehabilitation and recovery, with a mission to drive innovation for individuals with disabilities [3] - Lifeward's product portfolio includes the ReWalk Exoskeleton, AlterG Anti-Gravity System, ReStore Exo-Suit, and MyoCycle FES System [3] - Founded in 2001, Lifeward operates in the United States, Israel, and Germany [3] Leadership Changes - Bob Marshall has been a member of Lifeward's Board and Chair of the Audit Committee since 2024, bringing financial leadership and healthcare expertise to the role [2] - Prior to joining Lifeward, Bob Marshall served as Chief Financial Officer and Treasurer of Lantheus Holdings since 2018 and held various positions at Zimmer Biomet Holdings [2]

Core Viewpoint - Lifeward Ltd. will release its third quarter 2025 financial results on November 14, 2025, before market opening [1] Group 1: Financial Results Announcement - The financial results will be discussed in a conference call and live webcast hosted by the President and CEO, Mark Grant, and CFO, Almog Adar, at 8:30 a.m. EST on the same day [2] - Analysts and investors can access the call through various toll-free numbers and an access code referencing "Lifeward Earnings Call" [2] Group 2: Company Overview - Lifeward is a global leader in innovative medical technology aimed at transforming the lives of individuals with physical limitations or disabilities [1][3] - The company designs, develops, and commercializes solutions that provide functional and health benefits in both clinical and home settings [3] - Lifeward's product portfolio includes the ReWalk Exoskeleton, AlterG Anti-Gravity system, MyoCycle FES System, and ReStore Exo-Suit [3] Group 3: Company Background - Founded in 2001, Lifeward operates in the United States, Israel, and Germany [4] - The company's mission is to drive innovation to empower individuals with physical limitations [3][4]

Core Insights - Lifeward Ltd. has appointed Almog Adar as the new Chief Financial Officer, succeeding his previous role as Vice President of Finance and Chief Accounting Officer [1][3] - The appointment is seen as a strategic move to support the company's growth and strengthen its financial foundation [2][3] Company Overview - Lifeward is a global leader in innovative medical technology aimed at transforming the lives of individuals with physical limitations or disabilities [1][6] - The company designs, develops, and commercializes solutions that provide functional and health benefits in both clinical and home settings [6] - Lifeward's product portfolio includes notable innovations such as the ReWalk Exoskeleton, AlterG Anti-Gravity system, MyoCycle FES System, and ReStore Exo-Suit [6] Leadership Background - Almog Adar joined Lifeward in 2020 and has held various senior roles, contributing to the company's financial strategy and operations [3][4] - Prior to Lifeward, Mr. Adar gained extensive experience in financial management at Infinya Recycling Ltd. and Delta Galil Industries, as well as auditing at Ernst & Young [4][5] - He holds a Bachelor of Arts degree in Accounting and Economics and is a Certified Public Accountant licensed in Israel [5] Strategic Vision - Mr. Adar expressed commitment to enhancing Lifeward's execution and accelerating growth through a disciplined strategy [3] - The company aims to leverage its strengths to create lasting value for patients, customers, and shareholders [3] Company History - Lifeward was founded in 2001 and operates in the United States, Israel, and Germany [7] - The company's mission focuses on relentless innovation to improve the lives of individuals with physical limitations or disabilities [6]

Core Viewpoint - Lifeward Ltd. is set to release its second quarter 2025 financial results on August 14, 2025, before market opening, highlighting its ongoing commitment to innovation in medical technology for individuals with physical limitations or disabilities [1]. Company Overview - Lifeward designs, develops, and commercializes solutions aimed at physical rehabilitation and recovery, with a mission to drive innovation that transforms the lives of individuals with disabilities [3]. - The company's product portfolio includes notable innovations such as the ReWalk Exoskeleton, AlterG Anti-Gravity system, MyoCycle FES System, and ReStore Exo-Suit, which provide functional and health benefits in both clinical and home settings [3]. Financial Communication - The financial results will be discussed in a conference call and live webcast hosted by the President and CEO, Mark Grant, along with the Vice President of Finance, Almog Adar, scheduled for 8:30 a.m. EDT on the same day [2]. - Access to the conference call will be available through various toll-free numbers for different regions, and a live webcast will be accessible via the company's website [2].